Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 12 Nov 20 424B3 Prospectus supplement
- 12 Nov 20 EFFECT Notice of effectiveness
-
6 Nov 20 S-4/A Registration of securities issued in business combination transactions (amended)
- 28 Oct 20 S-4/A Registration of securities issued in business combination transactions (amended)
- 23 Sep 20 S-4 Registration of securities issued in business combination transactions
KANT similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statement on Form S-4 of Proteostasis Therapeutics, Inc. of our report dated March 10, 2020 relating to the financial statements, which appears in Proteostasis Therapeutics, Inc’s Annual Report on Form 10-K for the year ended December 31, 2019. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
November 6, 2020